Fiercely Pursuing and Delivering Therapies

Dedicated to quality and driven by excellence, we are committed to improving the lives of patients worldwide.

Creating Hope and New Opportunities

Our pipeline of cell therapies includes agents across hematologic and solid tumors. We focus on diseases that are considered intractable and incurable.

Transforming the World of Oncology and Medicine

We are a 1,000+ team driven by our passion for developing cutting-edge cell therapies.

Our news

Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights

Aug 15, 2023

Legend Biotech to Host Investor Conference Call on Second-Quarter Results

Aug 03, 2023

Legend Biotech Announces Submission of Supplemental Application to the U.S. FDA for Expanded Use of CARVYKTI® (ciltacabtagene autoleucel)

Jun 06, 2023

Ciltacabtagene Autoleucel (cilta-cel) Reduced Risk of Disease Progression or Death by 74% vs Standard Regimens for Adult Patients with Relapsed and Refractory Multiple Myeloma in CARTITUDE-4 Study

Jun 05, 2023

Legend Biotech Announces Submission to the European Medicines Agency for Expanded Use of CARVYKTI® (ciltacabtagene autoleucel)

May 25, 2023

Legend Biotech Reports First Quarter 2023 Results and Recent Highlights

May 18, 2023

Why we do what we do

We focus on serious and intractable diseases to help patients around the world.

PLAY VIDEO

Learn about us

Explore our technologies

We are technology agnostic in targeting hematologic malignancies and solid tumors. We are exploring 4 different technologies to help treat disease.

Meet our leadership team

Our leaders bring significant expertise from some of the world’s largest pharma companies.

Understand our capabilities

We are an end-to-end cell therapy company. Our capabilities extend from discovery to commercialization.

Work with us

We offer a variety of career choices that support the development of novel therapies.

Our pipeline

Our pipeline is comprised of investigational agents and innovative technologies in personalized medicine. We are devoted to exploring the potential of cell therapies to treat diseases that are considered intractable and incurable, including hematological malignancies and solid tumors.

LEARN MORE

We use cookies to improve your experience on our website, measure performance, understand our audience, for advertising and support purposes. You can always change your preferences or opt out from our use of cookies.